Karlsson_2012_Eur.J.Pharm.Sci_45_169

Reference

Title : Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation - Karlsson_2012_Eur.J.Pharm.Sci_45_169
Author(s) : Karlsson D , Fallarero A , Brunhofer G , Guzik P , Prinz M , Holzgrabe U , Erker T , Vuorela P
Ref : Eur J Pharm Sci , 45 :169 , 2012
Abstract :

In this contribution, a chemical collection of aromatic compounds was screened for inhibition on butyrylcholinesterase (BChE)'s hydrolase activity using Ellman's reaction. A set of diarylimidazoles was identified as highly selective inhibitors of BChE hydrolase activity and amyloid beta (Abeta) fibril formation. New derivatives were synthesized resulting in several additional hits, from which the most active was 6c, 4-(3-ethylthiophenyl)-2-(3-thienyl)-1H-imidazole, an uncompetitive inhibitor of BChE hydrolase activity (IC(5)(0) BChE=0.10 muM; K(i)=0.073 +/- 0.011 muM) acting also on Abeta fibril formation (IC(5)(0)=5.8 muM). With the aid of structure-activity relationship (SAR) studies, chemical motifs influencing the BChE inhibitory activity of these imidazoles were proposed. These bifunctional inhibitors represent good tools in basic studies of BChE and/or promising lead molecules for AD therapy.

PubMedSearch : Karlsson_2012_Eur.J.Pharm.Sci_45_169
PubMedID: 22108346

Related information

Citations formats

Karlsson D, Fallarero A, Brunhofer G, Guzik P, Prinz M, Holzgrabe U, Erker T, Vuorela P (2012)
Identification and characterization of diarylimidazoles as hybrid inhibitors of butyrylcholinesterase and amyloid beta fibril formation
Eur J Pharm Sci 45 :169

Karlsson D, Fallarero A, Brunhofer G, Guzik P, Prinz M, Holzgrabe U, Erker T, Vuorela P (2012)
Eur J Pharm Sci 45 :169